Osseon Therapeutics, a Santa Rosa, Calif.-based biomedical device company, received the FDA notice of allowance for its spinal vertebral compression technology as part of its Osseoplasty systems, according to a company news release.
The first generation of Osseoplasty was approved in 2009 and Osseon has upgraded the system with VCF technology.
Read the news release on spinal vertebral compression technology.
Read more coverage on VCF technology:
- RF Kyphoplasty Shows Less Cement Leakage Than Vertebroplasty
- Stryker Interventional Spine Launches iVAS Inflatable Vertebral Augmentation System
The first generation of Osseoplasty was approved in 2009 and Osseon has upgraded the system with VCF technology.
Read the news release on spinal vertebral compression technology.
Read more coverage on VCF technology:
- RF Kyphoplasty Shows Less Cement Leakage Than Vertebroplasty
- Stryker Interventional Spine Launches iVAS Inflatable Vertebral Augmentation System